MétaCan
Menu
← Back to cohort
Record W2921339284 · doi:10.1093/jcag/gwz006.207

A208 PREVALENCE OF FINANCIAL CONFLICTS OF INTEREST AMONG POINT-OF-CARE RESOURCE ARTICLES FOR INFLAMMATORY BOWEL DISEASE

2019· article· en· W2921339284 on OpenAlexaff
Michael A. Scaffidi, J Li, Rishad Khan, Nikko Gimpaya, Bianca Pivetta, Samir C. Grover

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2019
Typearticle
Languageen
FieldPharmacology, Toxicology and Pharmaceutics
TopicPharmaceutical industry and healthcare
Canadian institutionsUniversity of TorontoWestern UniversityQueen's University
Fundersnot available
KeywordsUlcerative colitisMedicaidInflammatory bowel diseasePaymentMedicineFamily medicineDiseaseConflict of interestMEDLINEPoint (geometry)Health careBusinessInternal medicineFinancePolitical science

Abstract

fetched live from OpenAlex

The use of point-of-care evidence-based medicine (POC-EBM) resources, such as UpToDate ®, is widespread. There are concerns, however, regarding the presence of physician-industry interactions and financial conflicts of interest (FCOI) among contributors to articles. In particular, it is unclear the extent to which articles on UpToDate ® regarding inflammatory bowel disease (IBD) have these potential conflicts of interest. To investigate the prevalence of industry payments from pharmaceutical companies making biologic medications for IBD among contributors to UpToDate articles on the treatment of IBD. We conducted a cross-sectional analysis of UpToDate ® articles related to the treatment of Crohn’s disease and ulcerative colitis that recommended the use of biologic medications. We collected the names of the contributors (authors, section editors, and deputy editors), and their disclosures on UpToDate were recorded. We then searched the names of those contributors on the Center for Medicare and Medicaid Open Payments (CMS-OP) database and compared the payment information from 2013 – 2016 with the disclosures on UpToDate ® . We presented data per episode, rather than by individual contributor. An episode describes one instance of participation in a by one person in one article, regardless of whether an author was present on multiple articles. We identified a total of 23 articles on the treatment of Crohn’s disease and ulcerative colitis that recommended the use of biologic medication, with a total of 86 episodes. Among these, we found that there were 42 (48.8%) declarations of FCOI, with 40 (46.5%) that were related to the company marketing the biologic recommended in the article. When examining the CMS-OP database for the relevant years, we found 39 (45.3%) records. The median value of all industry payments was 23 349.44 (USD). In addition, there were 35 episodes of industry payments that were related to the biologic mentioned in the article, with a median value of 41 656.00 (USD). Our results highlight a startling high prevalence of FCOI among a POC-EBM resource for the treatment of IBD. In particular, we found that almost half of the instances in these articles had relevant FCOI and the financial burden of related payments was substantial. Further work is needed to explore the relationships with these payments. None

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.032
metaresearch head score (Gemma)0.211
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Research integrity
Consensus categoriesnone
DomainCandidate signal: Incentives · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.999
Threshold uncertainty score0.167

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0320.211
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0310.033
Science and technology studies0.0010.001
Scholarly communication0.0040.005
Open science0.0020.003
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.121
GPT teacher head0.398
Teacher spread0.276 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designObservational
DomainIncentives
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of Gastroenterology→Same topicPharmaceutical industry and healthcare→French-language works237,207→